logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for cytx
Daily Contracts
21 Oct 14 11:50:00
Real-Time feed of company contracts, original agreements and executive updates from Cytori Therapeutics Inc $CYTX http://t.co/gqwpW5tHRQ
4-traders.com
21 Oct 14 03:10:25
CYTORI THERAPEUTICS : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) http://t.co/9Xj050JC9T $CYTX
$Stocknewsalerts
21 Oct 14 03:03:01
$CYTX Cytori - 8-K (Current report filing) SEC Filing From our Stock News Alerts App
4-traders.com
20 Oct 14 18:10:04
Cytori Therapeutics : Investor Note: Cytori Patents Automated Tissue Processing Device in Japan and Treatme... http://t.co/fPqRghqe9n $CYTX
Cytori IR
20 Oct 14 17:21:22
$CYTX Patents Automated Tissue Processing Device in Japan and Treatments for Wound Healing In China
Cytori IR
20 Oct 14 17:17:57
$CYTX Patents Automated Tissue Processing Device in Japan and Treatments for Wound Healing In China [http://t.co/bRxka5pTqf]
$Stocknewsalerts
20 Oct 14 17:15:37
$CYTX Cytori - Investor Note: Cytori Patents Automated Tissue Processing Device in Japan and Treatments for W From our Stock News Alerts App
Stock Moo
20 Oct 14 16:53:09
$cytx: Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 http://t.co/vj39XQlJJn
Stock Moo
20 Oct 14 16:53:08
$cytx: Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 http://t.co/bpGSyUbX6N
MAISA
20 Oct 14 15:58:39
$CYTX Announces Resignation of Lloyd H. Dean Effective November 1, 2014
mHealth Reporter
20 Oct 14 15:48:49
RT @BV_Healthcare: $CYTX Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014.. http://t.co/Uh6S8EGg…
Pzaa...Guy
20 Oct 14 15:48:10
$CYTX - Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 http://t.co/qA7Qh1gOfY
StockNews
20 Oct 14 15:48:07
$CYTX - Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 http://t.co/IVysMvU41Z
Stocks News&Markets
20 Oct 14 15:48:05
$CYTX - Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 http://t.co/LY4mkb5P6p
NASDAQ
20 Oct 14 15:48:02
$CYTX - Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 http://t.co/JCngIuCQrz
$Stocknewsalerts
20 Oct 14 15:46:19
$CYTX Cytori - Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014 From our Stock News Alerts App
BV Healthcare
20 Oct 14 15:46:08
$CYTX Cytori Therapeutics, Inc. Announces Resignation of Lloyd H. Dean Effective November 1, 2014.. http://t.co/Uh6S8EGgI9
Daily Contracts
20 Oct 14 10:43:08
Real-Time feed of company contracts, original agreements and executive updates from Cytori Therapeutics Inc $CYTX http://t.co/gqwpW5tHRQ
whutrades
17 Oct 14 05:33:37
$CYTX bottom bio ww; financing closed + Sabby filed 13G
TickerChirp
17 Oct 14 03:39:03
Top in Twitter Related to $CYTX on 10/17/2014 http://t.co/w0kTAvdlF5
4-traders.com
15 Oct 14 22:55:16
Cytori Therapeutics : to Raise $13.5 Million in Registered Direct Offering http://t.co/MvpTEuDUH3 $CYTX
FRAN BENEDITO
15 Oct 14 22:25:35
RT @theflynews: $CYTX Sabby reports 9.99% passive stake in Cytori Therapeutics: Full Story http://t.co/QsuFyuFina
Eli Pritsker
15 Oct 14 20:06:11
RT @FonsieTrader: Bullish MACD Crossovers 1/2 $ABIO $ATRS $AVG $CO $CYTX $ETH $GPT $GPX $HEB $IILG $INO $MHLD $MORL $NFBK $NWBI $NWBI http:…
mr13g
15 Oct 14 12:38:03
$CYTX SC 13G Filed By: Sabby Management, Llc, Subject: Cytori Therapeutics, Inc. http://t.co/9bTs22Q8oO
FilingsAnalysis
15 Oct 14 12:25:05
$CYTX, 13G filed by Sabby Management, LLC http://t.co/3diJ6mj5YO
Pzaa...Guy
15 Oct 14 11:49:14
$CYTX - Statement of Ownership (sc 13g) http://t.co/auKPEfL5bo
Pzaa...Guy
15 Oct 14 11:49:12
$CYTX - Statement of Ownership (sc 13g) http://t.co/DNp2NPZUoE
StockNews
15 Oct 14 11:49:11
$CYTX - Statement of Ownership (sc 13g) http://t.co/izgxh2lUPA
Stocks News&Markets
15 Oct 14 11:49:09
$CYTX - Statement of Ownership (sc 13g) http://t.co/EY6KW0QHZo
NASDAQ
15 Oct 14 11:49:02
$CYTX - Statement of Ownership (sc 13g) http://t.co/POeXAqtq1Y
whalewisdom
15 Oct 14 11:48:30
New SC 13G from SABBY MANAGEMENT, LLC concerning $CYTX. See details at http://t.co/0kcNTHdjql
The Fly
15 Oct 14 11:48:05
$CYTX Sabby reports 9.99% passive stake in Cytori Therapeutics: Full Story http://t.co/QsuFyuFina
$Stocknewsalerts
15 Oct 14 11:47:21
$CYTX Cytori - SC 13G (Statement of Ownership) SEC Filing From our Stock News Alerts App
Penny Stock Secret
15 Oct 14 11:44:29
Secret That Has Made GREG, And 22 of his friends and family members MILLIONAIRES! FIND HERE http://t.co/SVqoMkrw2z .. $CYTX $MPET $VBLT
4-traders.com
14 Oct 14 22:35:08
Cytori Therapeutics : Closes Financing http://t.co/GzaZQaLZDA $CYTX
Will.i.am
14 Oct 14 21:30:46
@supervaluemann if it does run..any sympathy plays? i found $stem but for paralysis, $cytx but for heart tissue..need another eyeball co
Daily Contracts
14 Oct 14 13:34:01
Real-Time feed of company contracts, original agreements and executive updates from Cytori Therapeutics Inc $CYTX http://t.co/gqwpW5tHRQ
MoneyEmpire
14 Oct 14 10:30:00
$CYTX :)))))))
The Cardiac Kid
14 Oct 14 10:07:47
ospreyeye: $CYTX: nice follow through today..............$$$: ospreyeye http://t.co/uwDeek41mx
MarkBagger
14 Oct 14 09:32:05
CYTX, .51 Bouncing, link back for chart. $CYTX http://t.co/Xlid7adfXq
MarkBagger
14 Oct 14 09:31:49
CYTX, .51 Bouncing, link back for chart. $CYTX http://t.co/K9gcciKISH
Large Void Bot
14 Oct 14 07:50:11
Daily Reversal (10:50): $CYTX Last: 0.5026; pHigh: 0.5000; rVol: 0.168; pClose: 0.4800; LOD: 0.4910; Perf: 4.7%
FonsieTrader
14 Oct 14 04:31:45
Bullish MACD Crossovers 1/2 $ABIO $ATRS $AVG $CO $CYTX $ETH $GPT $GPX $HEB $IILG $INO $MHLD $MORL $NFBK $NWBI $NWBI http://t.co/UxKi4pS1qh
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.